Tag Archives: Bilski

Prometheus v. Mayo and Classen v. Biogen Sent Back to Federal Circuit

Posted on June 29, 2010 by Warren Woessner

  Not unexpectedly, today the Supreme Court granted cert. in Prometheus v. Mayo, (09-490) vacated, and remanded to the Fed. Cir. for reconsideration in view of Bilski v. Kappos, decided yesterday. While this clears the Court’s collective desk, I don’t … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , | Leave a comment

Bilski Claims Fail As Attempt To Claim “Abstract Idea” – Future Of Business Method Patents Cloudy

Posted on June 28, 2010 by Warren Woessner

Today, the Supreme Court affirmed the rejection of Bilski’s claims. (Attached at end of posting.)  The 16 page Opinion of the Court was authored by Justice Kennedy, joined in full by Justices Thomas, Roberts, and Alito.  The opinion held that … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , | Leave a comment

WILL THE NIGHTMARE FOR BIOTECH PREP/PROS NEVER END?

Posted on February 1, 2010 by Warren Woessner

I recently gave a talk on patenting biomarkers, and was asked to talk about “push-back” by the courts and the PTO against getting useful patent claims in this emerging area (the gateway to “personalized medicine.” I was struck with how … Continue reading →

Posted in USPTO Practice and Policy | Tagged , , , , | Leave a comment

"LOOKS BAD FOR BUSINESS METHODS" — A note by Erwin J. Basinski

Posted on November 17, 2009 by Warren Woessner

The Bilski case before the US Supreme Court came up for oral argument on November 9. After a couple of reads, My initial impressions are: 1. Most of the questions from the Justices (primarily Scalia, Breyer, Roberts, Sotomeyor, Stevens, Kennedy, … Continue reading →

Posted in Patenting Methods/Processes | Tagged , , , , | Leave a comment